Gladstone in the News
The Gladstone Institutes is gratified to receive media attention from around the globe. Check out the highlights of recent press coverage of Gladstone scientists and research. For other news, please be sure to follow us on Facebook and Twitter.
A new type of cell could lead to dramatic cures—and avoid ethical controversy. The Smithsonian's Virginia Hughes speaks to Gladstone stem cell scientist Dr. Deepak Srivastava.
Seven years ago, the California stem cell research program was ready to give its very first grants. Voted into law in 2004, it had been delayed by lawsuits from the religious right and anti-tax groups for almost two years. But in 2006, Governor Schwarzenegger authorized a $150 million loan to the fledgling program. Prop 71 author Bob Klein persuaded philanthropists to help as well, and it was time.
Using a method called optical pulse-labeling (OPL), researchers from the Gladstone Institutes discovered for the first time that neurons’ inability to clear toxic proteins associated with Huntington’s disease is responsible for protein buildup, which eventually causes the neurons to wither away.
Researchers are building upon Shinya Yamanaka's Nobel prize-winning discovery to improve methods of creating iPS cells.
People with epilepsy appear to show signs of mild memory problems or Alzheimer's disease earlier than those without epilepsy, according to a new Gladstone study.
Gladstone researcher Lennart Mucke shares his thoughts on when there might be a cure for Alzheimer's disease.
University of California's Larissa Branin sits down with Gladstone's Steve Finkbeiner to discuss his latest research into learning and memory.
EDGE presents a Q&A with Warner C. Greene, MD, PhD, director of virology and immunology research at the Gladstone Institutes in San Francisco.
A key protein that has been linked to the body’s natural circadian clock may provide insights into how the body regulates vital metabolic functions, according to new research.
ISSCR President and Nobel Laureate Shinya Yamanaka, MD, PhD, describes his research career in stem cell biology and regenerative medicine.